Skip Navigation
Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​
NIH HHS News Release Logo

National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov

FOR IMMEDIATE RELEASE
Monday, July 26, 1999

Media Contact:
Diana Carroll
(301) 402-1663
niaidnews@niaid.nih.gov
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Dr. Carole Heilman Named Director of NIAID's Division of Microbiology and Infectious Diseases

Carole A. Heilman, Ph.D., was recently named director of the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). She comes to this position from NIAID's Division of AIDS, where she served as deputy director for the past three years.

"Dr. Heilman brings considerable experience and expertise to her new position," says Anthony S. Fauci, M.D., director of NIAID. "I am confident that she will bring her imaginative and creative leadership to address the future challenges in infectious disease research."

Dr. Heilman began her career at NIH in 1978 as a postdoctoral research associate with the National Cancer Institute where she carried out research on the regulation of gene expression during cancer development. In 1986, she came to NIAID as the influenza and viral respiratory diseases program officer in DMID and, in 1988, she was appointed chief of the respiratory diseases branch where she coordinated the development of acellular pertussis vaccines.

She joined the Division of AIDS as deputy director in 1997 and was responsible for developing the Innovation Grant Program for Approaches in HIV Vaccine Research. This program was created to encourage novel ideas and approaches in HIV vaccine research while stimulating interest from a new group of scientists, including those who had not been involved in HIV research. The program was designed to speed the pace of discovery and development of vaccines to prevent HIV infection.

As a member of the HIV Vaccine Innovation Grants Team, Dr. Heilman received the 1998 NIH Director's Award "for exceptional initiative, creativity and sustained productivity required for creation and implementation of the HIV Vaccine Innovation Grants Program." Most recently, she received the Secretary's Award for Distinguished Service for "exceptional leadership of the global efforts to identify a safe and effective vaccine to prevent AIDS." She also received the 1992 NIH Director's Award and the 1990 NIH Merit Award for her efforts in developing and implementing Cooperative Research and Development Agreements (CRADAs), collaborations between NIAID scientists and industry to enhance product development for improving public health.

Dr. Heilman received her bachelor's degree in biology from Boston University in 1972, and earned her master's degree and doctorate in microbiology from Rutgers University in 1976 and 1979, respectively.

Throughout her extramural career, Dr. Heilman has contributed articles on vaccine design and development to many scientific journals and has served as consultant to the World Bank and the World Health Organization in this area. She is also a member of several professional societies, including the Infectious Diseases Society of America; the American Society for Microbiology; and the American Society for Virology.


NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health ®

back to top


Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​​​

Last Updated July 26, 1999